QNI — Resorbable Implant For Anterior Cruciate Ligament (Acl) Repair Class II

FDA Device Classification

FDA product code QNI covers "Resorbable Implant For Anterior Cruciate Ligament (Acl) Repair", a Class II medical device regulated under 21 CFR 888.3044. Submissions are reviewed by the Orthopedic panel. Devices under this code are implants. At least 3 recent 510(k) clearances have been granted under this product code.

Classification Details

Product Code
QNI
Device Class
Class II
Regulation Number
888.3044
Submission Type
Review Panel
OR
Medical Specialty
Orthopedic
Implant
Yes

Definition

A resorbable implant for anterior cruciate ligament (ACL) repair is a degradable material that allows for healing of a torn ACL that is biomechanically stabilized by traditional suturing procedures. The device is intended to protect the biological healing process from the surrounding intraarticular environment and not intended to replace biomechanical fixation via suturing. This classification includes devices that bridge or surround the torn ends of a ruptured ACL.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K251214miach orthopaedicsBEAR® (Bridge-Enhanced ACL Restoration) ImplantJanuary 13, 2026
K243578miach orthopaedicsBEAR® (Bridge-Enhanced ACL Restoration) ImplantMarch 6, 2025
DEN200035miach orthopaedicsBEAR (Bridge-Enhanced ACL Repair) ImplantDecember 16, 2020